-
公开(公告)号:EP3214086A1
公开(公告)日:2017-09-06
申请号:EP15855181.2
申请日:2015-10-30
申请人: Ube Industries, Ltd.
发明人: AGA, Yasuhiro , USHIYAMA, Shigeru , IWASE, Noriaki , KONO, Shigeyuki , SUNAMOTO, Hidetoshi , MATSUSHITA, Takashi , OGI, Sayaka , TANAKA, Masayuki , MATOYAMA, Masaaki , UMEZAKI, Satoshi , SHIRAISHI, Yusuke , ONUMA, Kazuhiro , KOJIMA, Masahiro , NISHIYAMA, Hayato , KIMURA, Tomio
CPC分类号: C07F7/10 , A61K31/695 , Y02P20/55
摘要: Provided is a compound represented by formula (I) or a pharmacologically acceptable salt thereof:
wherein L 1 is an optionally substituted C 1-6 alkylene group or the like, L 2 is a single bond or the like, L 3 is a single bond or the like, R 1 , R 2 , and R 3 are each independently an optionally substituted C 1-4 alkyl group or the like, R 4 is a hydrogen atom or the like, and R 5 is a hydrogen atom or the like.摘要翻译: 提供由式(I)表示的化合物或其药理学上可接受的盐:其中L 1是任选取代的C 1-6亚烷基等,L 2是单键等,L 3是单键等, R1,R2和R3各自独立地为任选取代的C1-4烷基等,R4为氢原子等,R5为氢原子等。
-
2.
公开(公告)号:EP2940013A1
公开(公告)日:2015-11-04
申请号:EP13868493.1
申请日:2013-12-27
申请人: UBE Industries, Ltd.
发明人: IWASE, Noriaki , NISHIDA, Hiroshi , OKUDO, Makoto , ITO, Masaaki , KONO, Shigeyuki , MATOYAMA, Masaaki , USHIYAMA, Shigeru , OKANARI, Eiji , MATSUNAGA, Hirofumi , NISHIKAWA, Kenji , KIMURA, Tomio
IPC分类号: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C07D409/04 , C07D409/14 , C07D417/12
CPC分类号: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/00 , A61P43/00 , C07D409/04 , C07D409/12 , C07D409/14 , C07D417/12
摘要: A novel α-halogen-substituted thiophene compound or a pharmacologically acceptable salt thereof, which has a potent LPA receptor-antagonist activity and is useful as a medicament is provided.
A compound represented by the general formula (I) wherein A represents, a phenyl ring, a thiophene ring, or an isothiazole ring; R 1 is the same or different, and represents a halogen atom, or a C 1 -C 3 alkyl group; R 2 represents a hydrogen atom, or a C 1 -C 6 alkyl group; p represents an integer of 0 to 5; V represents CR 3 wherein R 3 represents a hydrogen atom, an amino group, a nitro group, or a C 1 -C 3 alkoxy group, or V represents a nitrogen atom; and X represents a halogen atom, or a salt thereof.摘要翻译: 提供了一种具有有效的LPA受体 - 拮抗剂活性并可用作药物的新型的 - - 卤素取代的噻吩化合物或其药学上可接受的盐。 由通式(I)表示的化合物,其中A表示苯基环,噻吩环或异噻唑环; R 1相同或不同,表示卤素原子或C 1〜C 3烷基; R 2表示氢原子或C 1 -C 6烷基; p表示0〜5的整数, V表示CR 3,其中R 3表示氢原子,氨基,硝基或C 1 -C 3烷氧基,或V表示氮原子; X表示卤素原子或其盐。
-
公开(公告)号:EP3162801B1
公开(公告)日:2020-07-22
申请号:EP15812460.2
申请日:2015-06-26
申请人: UBE Industries, Ltd.
发明人: IWASE, Noriaki , NISHIDA, Hiroshi , OKUDO, Makoto , ITO, Masaaki , KONO, Shigeyuki , MATOYAMA, Masaaki , USHIYAMA, Shigeru , OKANARI, Eiji , MATSUNAGA, Hirofumi , NISHIKAWA, Kenji , KIMURA, Tomio
IPC分类号: C07D333/36 , A61K31/381 , A61P13/00 , A61P19/04 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00
-
公开(公告)号:EP2940013B1
公开(公告)日:2018-02-21
申请号:EP13868493.1
申请日:2013-12-27
申请人: UBE INDUSTRIES, LTD.
发明人: IWASE, Noriaki , NISHIDA, Hiroshi , OKUDO, Makoto , ITO, Masaaki , KONO, Shigeyuki , MATOYAMA, Masaaki , USHIYAMA, Shigeru , OKANARI, Eiji , MATSUNAGA, Hirofumi , NISHIKAWA, Kenji , KIMURA, Tomio
IPC分类号: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C07D409/04 , C07D409/14 , C07D417/12
CPC分类号: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/00 , A61P43/00 , C07D409/04 , C07D409/12 , C07D409/14 , C07D417/12
摘要: A novel ±-halogen-substituted thiophene compound or a pharmacologically acceptable salt thereof, which has a potent LPA receptor-antagonist activity and is useful as a medicament is provided. A compound represented by the general formula (I) wherein A represents, a phenyl ring, a thiophene ring, or an isothiazole ring; R 1 is the same or different, and represents a halogen atom, or a C 1 -C 3 alkyl group; R 2 represents a hydrogen atom, or a C 1 -C 6 alkyl group; p represents an integer of 0 to 5; V represents CR 3 wherein R 3 represents a hydrogen atom, an amino group, a nitro group, or a C 1 -C 3 alkoxy group, or V represents a nitrogen atom; and X represents a halogen atom, or a salt thereof.
-
-
-